bioAffinity Technologies Files 8-K
Ticker: BIAFW · Form: 8-K · Filed: Jul 22, 2025 · CIK: 1712762
Sentiment: neutral
Topics: 8-k, filing, financials
Related Tickers: BIAF
TL;DR
BIAF filed an 8-K on 7/22/25 for other events and financials.
AI Summary
On July 22, 2025, bioAffinity Technologies, Inc. filed a Form 8-K to report other events and financial statements. The company, incorporated in Delaware with its principal executive offices in San Antonio, Texas, is involved in commercial physical and biological research.
Why It Matters
This filing indicates bioAffinity Technologies, Inc. is providing updates on its corporate activities and financial status to the SEC.
Risk Assessment
Risk Level: low — This is a routine filing of an 8-K, which typically reports significant corporate events or financial updates.
Key Numbers
- 001-41463 — SEC File Number (Identifier for the company's filings with the SEC)
- 46-5211056 — EIN (Employer Identification Number)
Key Players & Entities
- bioAffinity Technologies, Inc. (company) — Registrant
- July 22, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- San Antonio, Texas (location) — Principal executive offices
- 8731 (sic_code) — Standard Industrial Classification
FAQ
What specific 'Other Events' are being reported by bioAffinity Technologies, Inc. in this 8-K filing?
The filing indicates 'Other Events' as an item information, but the specific details of these events are not provided in the header information.
What is the nature of the financial statements being filed with this 8-K?
The filing lists 'Financial Statements and Exhibits' as an item information, but the specific content or period covered by these statements is not detailed in the header.
When was bioAffinity Technologies, Inc. incorporated, and in which state?
bioAffinity Technologies, Inc. was incorporated in Delaware, as stated in the filing.
What is the primary business activity of bioAffinity Technologies, Inc. according to its SIC code?
According to its Standard Industrial Classification code (8731), bioAffinity Technologies, Inc. is involved in 'SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH'.
What is the physical address of bioAffinity Technologies, Inc.'s principal executive offices?
The principal executive offices of bioAffinity Technologies, Inc. are located at 3300 Nacogdoches Road, Suite 216, San Antonio, Texas 78217.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 22, 2025 regarding bioAffinity Technologies, Inc. (BIAFW).